+
+

Related Products

  • SciSure
    298 Ratings
    Visit Website
  • StackAI
    53 Ratings
    Visit Website
  • Lockbox LIMS
    72 Ratings
    Visit Website
  • RegDesk
    19 Ratings
    Visit Website
  • SAP S/4HANA Cloud Public Edition
    4,265 Ratings
    Visit Website
  • QBench
    143 Ratings
    Visit Website
  • Qualio
    858 Ratings
    Visit Website
  • Windocks
    7 Ratings
    Visit Website
  • BrandMap® 10
    Visit Website
  • Harmoni
    16 Ratings
    Visit Website

About

GPT-Rosalind is a purpose-built frontier reasoning model developed by OpenAI to accelerate scientific research across biology, drug discovery, and translational medicine. It is designed specifically for life sciences workflows, where researchers must navigate large volumes of literature, experimental data, and specialized databases to generate and validate new ideas. It combines deep domain understanding in areas such as chemistry, genomics, protein engineering, and disease biology with advanced tool-use capabilities, allowing it to interact with scientific databases, analyze experimental outputs, and support complex, multi-step reasoning tasks. It can assist with evidence synthesis, hypothesis generation, literature review, sequence interpretation, and experimental planning, helping scientists move faster from raw data to actionable insights. GPT-Rosalind transforms complex, time-intensive research processes into more efficient AI-assisted workflows.

About

Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Bioinformaticians, computational biologists, and pharmaceutical research teams who need AI to accelerate hypothesis generation, data analysis, and experimental design in life sciences

Audience

Recursion is ideal for researchers, pharmaceutical partners, investors, and healthcare stakeholders interested in AI-driven drug discovery and next-generation therapeutic development

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

OpenAI
Founded: 2015
United States
openai.com/index/introducing-gpt-rosalind/

Company Information

Recursion
United States
www.recursion.com

Alternatives

Alternatives

Categories

Categories

Integrations

ChatGPT
Codex CLI
OpenAI

Integrations

ChatGPT
Codex CLI
OpenAI
Claim GPT-Rosalind and update features and information
Claim GPT-Rosalind and update features and information
Claim Recursion and update features and information
Claim Recursion and update features and information